Enhanced delivery of adenovirus, using proteoliposomes containing wildtype or V156K Apolipoprotein A-I and dimyristoylphosphatidylcholine

Human Gene Therapy

Volumn 21, Issue 5, 2010, Pages 579-587

  Park, Ki Hoon ^a   Yun, Chae Ok ^b   Kwon, Oh Joon ^b   Kim, Cheol Hee ^c   Kim, Jae Ryong ^a   Cho, Kyung Hyun ^a  

^a Yeungnam University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; APOLIPOPROTEIN A1; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; GREEN FLUORESCENT PROTEIN; GUANIDINE; LIPOSOME; LYSINE; VALINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CELL; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER CELL; NONHUMAN; PARTICLE SIZE; PHOSPHOLIPID BILAYER; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE; WILD TYPE; ZEBRA FISH;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEIN A-I; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; GUANIDINE; HUMANS; LIPOSOMES; PROTEOLIPIDS; ZEBRAFISH;

ADENOVIRIDAE; DANIO RERIO;

EID: 77951954997     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.207     Document Type: Article

References (26)

1. Ansell, B.J., Watson, K.E., Fogelman, A.M., Navab, M., and Fo-narow, G.C. (2005). High density lipoprotein function. J. Am. Coll. Cardiol. 46, 1792-1798.
2. Barter, P.J., Nicholls, S., Rye, K.A., Anantharamaiah, G.M., Na-vab, M., and Fogelman, A.M. (2004). Antiinflammatory properties of HDL. Circ. Res. 95, 764-772.
3. Chen, P.S., Toribara, T.Y., and Warner, H. (1956). Micro-determination of phosphorus. Anal. Chem. 28, 1756-1758.
4. Cho, K.H., and Jonas, A. (2000). A key point mutation (V156E) affects the structure and functions of human apolipoprotein A-I. J. Biol. Chem. 275, 26821-26827.
5. Cho, K.H., and Kim, J.R. (2009). A reconstituted high-density lipoprotein containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation. Exp. Mol. Med. 41, 417-428.
6. Cho, K.H., Park, S.H., Han, J.M., Kim, H.C., Choi, Y.K., and Choi, I. (2006). ApoA-I mutants V156K and R173C promote anti-inflammatory function and antioxidant activities. Eur. J. Clin. Invest. 36, 875-882.
7. Cho, K.H, Park, S.H., Han, J.M., Kim, H.C., Chung, Y.J., Choi, I., and Kim, J.R. (2007). A point mutant of apolipoprotein A-I, V156K, exhibited potent anti-oxidant and anti-atherosclerotic activity in hypercholesterolemic C57BL=6 mice. Exp. Mol. Med. 39, 160-169.
8. Felgner, P.L. (1996). Improvements in cationic liposomes for in vivo gene transfer. Hum. Gene Ther. 15, 1791-1793.
9. Han, J.M., Jeong, T.S., Lee, W.S., Choi, I., and Cho, K.H. (2005). Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. J. Lipid Res. 46, 589-596.
10. Heider, J.G., and Boyett, R.L. (1978). The picomole determination of free and total cholesterol in cells in culture. J. Lipid Res. 19, 514-518.
11. Jonas, A., Wald, J.H., Toohill, K.L., Krul, E.S., and Kézdy, K.E. (1990) Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. J. Biol. Chem. 265, 22123-22129. (Pubitemid 120014276)
12. Kawasaki, T., Saito, K., Mitsui, K., Ikawa, M., Yamashita, M., Taniguchi, Y., Takeda, S., Mitani, K., and Sakai, N. (2009). Introduction of a foreign gene into zebrafish and medaka cells using adenoviral vectors. Zebrafish 6, 253-258.
13. Lacko, A.G., Nair, M., Paranjape, S., Johnson, S., and McConathy, W.J. (2002). High density lipoprotein complexes as delivery vehicles for anticancer drugs. Anticancer Res. 22, 2045-2049.
14. Lou, B., Liao, X.L., Wu, M.P., Cheng, P.F., Yin, C.Y., and Fei, Z. (2005). High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells. World J. Gastroenterol. 11, 954-959.
15. Markwell, M.A., Haas, S.M., Bieber, L.L., and Tolbert, N.E. (1978). A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206-210.
16. McConnell, M.J., and Imperiale, M.J. (2004). Biology of adeno-virus and its use as a vector for gene therapy. Hum. Gene Ther. 15, 1022-1033.
17. Navab, M., Hama, S., Hough, G., and Fogelman, A.M. (2003). Oral synthetic phospholipid (DMPC) raises high-density li-poprotein cholesterol levels, improves high-density lipopro-tein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice. Circulation 108, 1735-1739.
18. Oda, M.N., Hargreaves, P.L., Beckstead, J.A., Redmond, K.A., Van Antwerpen, P., and Ryan, R.O. (2006). Reconstituted high density lipoprotein enriched with the polyene antibiotic am-photericin B. J. Lipid Res. 47, 260-267.
19. Petrella, J., Cohen, C.J., Gaetz, J., and Bergelson, J.M. (2002) A zebrafish coxsackievirus and adenovirus receptor homologue interacts with coxsackie B virus and adenovirus. J. Virol. 76, 10503-10506
20. Pownall, H.J., Massey, J.B., Kusserow, S.K., and Gotto, A.M., Jr. (1978). Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human plasma high density lipo-proteins with phosphatidylcholines. Biochemistry 17, 1183-1188.
21. Staros, J.V. (1982). N-hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry 21, 3950-3955.
22. Steel, J.C., Cavanagh, H.M.A., Burton, M.A., Dingwall, D.J., and Kalle, W.H.J. (2005). Modification of liposomal concentration in liposome=adenoviral complexes allows significant protection of adenoviral vectors from neutralising antibody, in vitro. J. Virol. Methods 126, 31-36.
23. Steel, J.C., Cavanagh, H.M.A., Burton, M.A., Abu-Asab, M.S., Tsokos, M., Morris, J.C., and Kalle, W.H.J. (2007). Increased tumor localization and reduced immune response to adeno-viral vector formulated with the liposome DDAB=DOPE. Eur. J. Pharm. Sci. 30, 398-405.
24. Trede, N.S., Zapata, A., and Zon, L.I. (2001) Fishing for lym-phoid genes. Trends Immunol. 22, 302-307.
25. Walldius, G., and Jungner, I. (2007). Apolipoprotein A-I versus HDL-cholesterol in the prediction of risk for myocardial infarction and stroke. Curr. Opin. Cardiol. 22, 359-367.
26. Yang, Y., Nunes, F.A., Berencsi, K., Furth, E.E., Gönczöl, E., and Wilson, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 91, 4407-4411.